Gene Salkind

CIK 1592481 · last filed 2026-02-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$717.4K

Companies

5

Total Filings

43

Lifetime Open-Market Net

$1.86M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Z Squared Inc. (COEPW) Delisted Director 17,207 $0.01 $179 $38.1K 5 2026-02-13
UPXI Director 788,220 $0.91 $717.4K $1.32M 5 2025-11-21
Mobiquity Technologies, Inc. (MOBQW) Delisted Director 448,535 $0.01 $3.5K $0 8 2023-11-09
UPEXI, INC. (GRVI) Delisted Director 2,477,942 $4.95 $12.27M $500.0K 2 2022-04-01
DermTech, Inc. (DMTK) Delisted Director 179,154 $0.09 $16.8K $0 2 2020-02-03

Recent Filings · Page 4 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-04-01 Grant (A) $0
2020-09-09 Grant (A) +15,000,000 $150.0K
2020-08-04 Grant (A) +15,000,000 $150.0K
2020-02-03 DermTech, Inc. (DMTK) Delisted Grant (A) +6,000 $0 EDGAR
2020-01-21 Mixed +175,000,000 $3.19M
2020-01-03 DermTech, Inc. (DMTK) Delisted Exer (M) +7,593 $0 EDGAR
2019-09-19 Mixed +175,000,000 $3.19M
2019-07-29 Grant (A) +12,500,000 $500.0K
2019-07-29 Grant (A) +3,125,000 $250.0K
2019-07-29 Grant (A) +3,125,000 $250.0K
Showing 3140 of 43
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.